The government plans to tighten the regulatory noose around pharmaceuticals imports from China through stricter scrutiny of active pharmaceutical ingredients (APIs), key starting materials (KSMs) for medicines and medical equipments.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3fMmlMQ
